1. India Stocks

  2. •

    Process industries

  3. •

    Chemicals: major diversified
Paushak Limited

Paushak Limited

619.75
INR
-40.25
(-6.10%)
17.19EPS
29.38P/E
12.45BMarket Cap
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
2026 Y
TTM
Revenue per Share
21.06
26.89
30.36
25.66
39.59
55.27
55.24
56.59
60.23
85.48
83.08
84.98
88.04
99.87
Basic EPS, GAAP
3.44
5.06
4.84
4.26
8.37
15.71
14.16
15.13
15.25
21.9
22.04
20.03
15.95
17.19
Free Cash Flow per Basic Share
2.09
0.1
-1.18
2.68
1.89
5.31
9.83
-10.53
-1.73
10.37
6.87
-49.83
-13.97
- -
Dividend per Share
0.35
0.35
0.35
0.37
0.37
0.37
0.62
0.75
0.75
1.49
2.16
2.45
2.45
- -
Book Value per Share
142.41
178.96
231.7
258.86
352.75
576.12
737.29
881.42
991.4
1,147.57
1,324.17
1,510.29
199.18
- -
Tangible Book Value per Share
142.41
178.96
231.7
258.86
352.75
576.02
737.06
880.82
990.98
1,147.28
1,324.01
1,510.12
199.17
- -
Basic Weighted Avg Shares
26
26
26
26
26
25
25
25
25
25
25
25
25
25
Sales/Revenue/Turnover
540
690
779
658
1,016
1,371
1,362
1,395
1,485
2,108
2,048
2,095
2,171
2,463
Operating Margin (%)
20.47
24.63
19.26
13.95
25.95
26.6
28.23
32.66
30.54
29.35
25.2
21.71
18.44
17.41
Depreciation Expense
18
21
28
32
34
39
44
50
90
134
138
150
214
257
Net Income, GAAP
88
130
124
109
215
390
349
373
376
540
544
494
393
424
Effective Tax Rate (%)
30.1
27.76
25.24
22.49
25.62
20.48
23.06
27.7
25.19
25.22
23.44
15.99
21.99
21.21
Profit Margin (%)
16.32
18.84
15.94
16.62
21.14
28.41
25.63
26.73
25.32
25.62
26.53
23.57
18.11
17.21
Working Capital
251
289
299
191
334
751
943
677
765
1,249
1,896
551
662
- -
LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
250
600
- -
Total Equity
457
574
743
830
1,131
1,776
2,272
2,717
3,056
3,537
4,081
4,655
4,911
- -
Return on Invested Capital (%)
20.56
24.91
16.81
8.96
19.73
24.98
15.41
13.21
11.69
14.33
10.3
8.45
5.82
- -
Return on Capital (%)
20.93
25.16
18.76
13.88
21.83
26.75
17.25
14.95
13.04
16.44
14.29
11.01
7.59
- -
Return on Common Equity (%)
21.09
25.21
18.86
13.91
21.89
26.8
17.25
14.95
13.03
16.38
14.27
11.3
8.22
- -

Capital Structure

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
ST Debt
- -
169
- -
LT Borrowings
- -
600
- -
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
25
25
25
Market Capitalization
14,635
8,521
12,452

Working Capital

INR

•

in mil. unless spec.
Dec'26
Mar'26
Jun'27
Total Current Assets
- -
1,317
- -
Cash, Cash Equivalents & STI
- -
274
- -
Accounts Receivable, Net
- -
549
- -
Inventories
- -
366
- -
Total Current Liabilities
- -
654
- -
Payables & Accruals
- -
- -
- -
ST Debt
- -
169
- -
Deferred Revenue
- -
- -
- -

Growth Rates

INR

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
21.57%
12.64%
5.51%
Free Cash Flow
-202.08%
-342.7%
-71.97%
Net Income, GAAP
17.78%
3.11%
-20.36%
Sales/Revenue/Turnover
12.7%
10.29%
3.61%
Total Cash Common Dividend
24.55%
31.46%
-0.02%

Quarterly Revenue

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
520
573
493
524
2,095
2026
559
588
488
551
2,171
2027
836
- -
- -
- -
- -

Quarterly Earnings Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
4.18
5.76
6.19
3.9
20.03
2026
4.88
3.49
2.5
5.07
15.95
2027
6.13
- -
- -
- -
- -

Quarterly Dividends Per Share

INR

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2025
- -
- -
- -
- -
2.45
2026
- -
- -
- -
- -
2.45
2027
- -
- -
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Kirti Shah
Full Time Employees
683
Sector
Process industries
Industry
Chemicals: major diversified
Address
Alembic Road Vadodara GU India 390003
IPO Date
May 11, 2006
Website
paushak.com
Similar Companies
Hektas Ticaret T.A.S. (BIST:HEKTS)
AARTI Industries Ltd (NSE:AARTIIND)
Aether Industries Ltd. (NSE:AETHER)
Mitsui & Co.,Ltd (TSE:8031)
Saudi Basic Industries Corp. (TADAWUL:2010)
Raghav Productivity Enhancers Ltd. (NSE:RPEL)
Business
Paushak Limited is a specialty chemicals company primarily engaged in the production of phosgene gas and phosgene-based specialty chemicals and intermediates, including isocyanates, chloroformates, and chlorides. It also offers contract development and manufacturing organization (CDMO) services, advanced research and development capabilities for proprietary molecules, and engineering and design services. The company serves pharmaceutical, agrochemical, and other industrial sectors with multipurpose plants capable of handling complex manufacturing requirements at various scales. It operates globally with a strong focus on safe, sustainable, and reliable phosgene chemistry and supply security. Founded in 1968 and headquartered in India, Paushak is recognized as the largest phosgene-based specialty chemical producer in India. Recent major developments include a strategic expansion approved by Indian authorities to triple its phosgene production capacity from 4,800 metric tons to 14,400 metric tons, funded through internal accruals, aimed at achieving economies of scale and enhancing cost competitiveness globally. Paushak has launched innovative products such as the patented, CIB-approved agricultural yield enhancer "Paushak Super Star," developed with advanced research collaborations to improve crop growth and soil health. The company has also announced a stock split and bonus issue in 2025 to enhance liquidity. Paushak continues to pursue import substitution by developing indigenous technology for key specialty chemicals, reinforcing its position in the domestic and international markets. It is part of a group structure involving Alembic Limited and related entities, focusing on vertical integration and simplification of operations.